REFERENCES
  1. Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol 2020 May 2. doi: 10.1111/pai.13271.
  2. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008;4:80-90.
  3. Mirijello A, Tosoni A, Zaccone V, Impagnatiello M, Passaro G, Vallone CV, et al. MEDS score and vitamin D status are independent predictors of mortality in a cohort of Internal Medicine patients with microbiological identified sepsis. Eur Rev Med Pharmacol Sci 2019;23:4033-4043.
  4. Li Y, Ding S. Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis. BMC Infect Dis 2020;20:189.
  5. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020;12. pii: E988. doi: 10.3390/nu12040988.
  6. Marik PE, Kory P, Varon J. Does vitamin D status impact mortality from SARS-CoV-2 infection? Med Drug Discov 2020 Apr 29:100041. doi: 10.1016/j.medidd.2020.100041.
  7. Silberstein M. Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? Med Hypotheses 2020;140:109767. doi: 10.1016/j.mehy.2020.109767.